O'Morain Neil Robert, O'Donovan Helen, Conlon Caroline, Shannon Eileen, Manning Diarmuid, Slattery Eoin
Department of Gastroenterology, University Hospital Galway, Galway, Ireland.
Clin Endosc. 2021 Jul;54(4):548-554. doi: 10.5946/ce.2020.236. Epub 2021 Jan 13.
BACKGROUND/AIMS: Gastric antral vascular ectasia (GAVE) is a rare acquired vascular lesion of the gastric antrum. The most frequent presentation of GAVE is iron deficiency anemia. Endoscopic therapy is the mainstay of treatment. However, there is no consensus regarding the optimal treatment modality.
A retrospective cohort study was performed on patients with GAVE, including patients receiving endoscopic therapy. Treatment was with either argon plasma coagulation (APC) or endoscopic band ligation (EBL). Basic demographic data, indication for index procedure, number of sessions, and pre- and post-hemoglobin levels were collected. The aim of the study was to compare outcomes across the two treatment modalities.
One hundred and seventeen diagnoses of GAVE were made. Sixty-two patients (53%) required endoscopic treatment for symptomatic GAVE (female, n=38, 61%; mean age of 74.4 years). Two hundred and eighteen procedures were performed during the study period. APC was performed (n=161, 74%) more frequently than EBL (n=57, 26%). Patients treated with APC at index required a median 5 subsequent therapeutic interventions (APC or EBL), while those treated with EBL at index required a further 2.9 treatments (EBL only) (p<0.05).
APC was the most common treatment modality employed. We demonstrate an increasing incidence of EBL. Patients treated with EBL at index treatment required fewer subsequent treatment sessions and had a greater mean rise in hemoglobin. This suggests a more effective endoscopic response with EBL.
背景/目的:胃窦血管扩张症(GAVE)是一种罕见的获得性胃窦血管病变。GAVE最常见的表现是缺铁性贫血。内镜治疗是主要的治疗方法。然而,关于最佳治疗方式尚无共识。
对GAVE患者进行回顾性队列研究,包括接受内镜治疗的患者。治疗采用氩等离子体凝固术(APC)或内镜下套扎术(EBL)。收集基本人口统计学数据、首次手术指征、手术次数以及血红蛋白水平的术前和术后数据。本研究的目的是比较两种治疗方式的疗效。
共确诊117例GAVE。62例(53%)有症状的GAVE患者需要内镜治疗(女性,n = 38,61%;平均年龄74.4岁)。研究期间共进行了218次手术。APC的实施频率(n = 161,74%)高于EBL(n = 57,26%)。首次接受APC治疗的患者随后需要进行中位数为5次的治疗干预(APC或EBL),而首次接受EBL治疗的患者则需要进一步进行2.9次治疗(仅EBL)(p < 0.05)。
APC是最常用的治疗方式。我们发现EBL的发生率在增加。首次接受EBL治疗的患者后续治疗次数较少,血红蛋白平均升高幅度更大。这表明EBL的内镜反应更有效。